Utah Medical Products reported $98.42M in Equity Capital and Reserves for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Angiodynamics ANGO:US $ 454.34M 0.71M
Antares Pharma ATRS:US $ 65.24M 7.91M
Baxter International BAX:US $ 8689M 122M
Cerulean Pharma CERU:US $ -1.39M 1.7M
Cerus CERS:US $ 109.24M 5.29M
General Electric GE:US $ 35552M 2283M
Integra Lifesciences IART:US $ 1514.87M 116.88M
Meridian Bioscience VIVO:US $ 278.87M 31.24M
Orasure Technologies OSUR:US $ 387.89M 6.14M
Rockwell Medical RMTI:US $ 42.08M 25.86M
Sientra SIEN:US $ 18.08M 4M
Staar Surgical STAA:US $ 197.22M 10.83M
Stryker SYK:US $ 13084M 98M
Utah Medical Products UTMD:US $ 98.42M 3.13M
West Pharmaceutical Services WST:US $ 1854.5M 135.6M